Brief: Shandong Boan Biotechnology Expects Net Loss Attributable Of RMB79 Million-RMB89 Million
14/08/2026 15:17
BRIEF-Shandong Boan Biotechnology Expects Net Loss Attributable Of RMB79 Million-RMB89 Million Aug 14 (Reuters) - Shandong Boan Biotechnology Co Ltd 6955.HK:
EXPECTS NET LOSS ATTRIBUTABLE OF RMB79 MILLION-RMB89 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026
EXPECTED TURNAROUND TO LOSS MAINLY DUE TO INCREASED RESEARCH AND DEVELOPMENT EXPENDITURE IN HY
Further company coverage: 6955.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shandong Boan Biotechnology
See all newsBrief: Shandong Boan Biotechnology Says CDE Clears IND Application For BA1203
Brief: Shandong Boan Biotechnology Co Says Industrial Bank Financial Leasing Will Purchase Leased Assets From Co
Brief: Shandong Boan Biotechnology Announces CDE IND Application Acceptance For TLLA/IL-23 Bispecific Antibody BA2201
Brief: Shandong Boan Biotechnology Expects Net Loss Attributable Of RMB79 Million-RMB89 Million
Brief: Shandong Boan Biotechnology Submits BLA For BA9101 To Anvisa In Brazil